Science Explorer Interactive view Map
Research facility · Alessandria · Italy

Fondazione Intergruppo Italiano Linfomi Onlus

Research works
41
▲ 18% vs 2013–17
Citations
309
7.6 per fractional work
Top-10% rate
23.8%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Fondazione Intergruppo Italiano Linfomi Onlus is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.82× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.00× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.99× its world share, 0 worksPharmacology, Toxico…Health Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 3.96× its world share, 4 worksMedicineBusiness, Management and Accounting: 2.62× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.70× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Which keywords describe research at Fondazione Intergruppo Italiano Linfomi Onlus?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Lymphoma, PET Imaging, Classification, Molecular Profiling, Prognostic Factors, Therapeutic Targets and Chronic Lymphocytic Leukemia.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab14▲ 211×2 topics
  2. Lymphoma11▲ 182×3 topics
  3. PET Imaging10▲ 115×3 topics
  4. Classification10▲ 67×1 topic
  5. Molecular Profiling10▲ 205×1 topic
  6. Prognostic Factors7▲ 36×6 topics
  7. Therapeutic Targets4▲ 41×2 topics
  8. Chronic Lymphocytic Leukemia4▲ 192×1 topic
  9. Genomic Aberrations4▲ 192×1 topic
  10. Chemotherapy3▲ 9.3×12 topics
  11. Immunotherapy2▲ 7.7×8 topics
  12. Quality of Life2▲ 3.6×15 topics
  13. Radiotherapy2▲ 13×6 topics
  14. Prognostic Scoring System2▲ 122×2 topics
  15. Minimal Residual Disease2▲ 64×2 topics
  16. Acute Lymphoblastic Leukemia2▲ 107×1 topic
  17. Cancer Incidence2▲ 27×4 topics
  18. Childhood Cancer2▲ 107×1 topic
  19. Clinical Trials2▲ 6.2×6 topics
  20. Methotrexate2▲ 246×1 topic
  21. Primary CNS Lymphoma2▲ 246×1 topic
  22. Treatment2▲ 2.8×8 topics
  23. Palliative Care1▲ 19×3 topics
  24. Ethical Considerations1▲ 8.8×2 topics
  25. Targeted Therapy1▲ 14×3 topics
  26. Advance Care Planning1▲ 48×1 topic
  27. Cancer Immunotherapy1▲ 19×2 topics
  28. End-of-Life1▲ 34×2 topics
  29. Epstein-Barr Virus1▲ 87×1 topic
  30. Family Perspectives1▲ 48×1 topic
  31. Fc Receptors1▲ 26×1 topic
  32. Glycosylation1▲ 12×2 topics
  33. Immunosuppression1▲ 24×2 topics
  34. Kaposi's Sarcoma1▲ 87×1 topic
  35. Leukemia1▲ 43×2 topics
  36. Therapeutic Antibodies1▲ 20×1 topic
  37. ALK Inhibitors1▲ 46×1 topic
  38. CAR T Cells1▲ 59×1 topic
  39. Chimeric Antigen Receptor1▲ 59×1 topic
  40. EGFR Mutations1▲ 46×1 topic

Which research topics does Fondazione Intergruppo Italiano Linfomi Onlus publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Big Data and Business Intelligence, Chronic Lymphocytic Leukemia Research and Cytokine Signaling Pathways and Interactions.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  2. 2 Big Data and Business Intelligence Management Information Systems 0 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
  5. 5 Bone health and osteoporosis research Orthopedics and Sports Medicine 0 works
  6. 6 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  7. 7 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
  8. 8 Vitamin D Research Studies Pathology and Forensic Medicine 0 works
  9. 9 Genetic Syndromes and Imprinting Genetics 0 works
  10. 10 Parathyroid Disorders and Treatments Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.5%not open68.5%

World: 28% of research is openly available.

with international co-authors24.0%domestic only76.0%

World: 19% is written across borders.

How has Fondazione Intergruppo Italiano Linfomi Onlus's research output changed?

Output in 2018–2022 was 18% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Alessandria

All research institutions in Alessandria

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.